Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:2/19/2020)... ... February 19, 2020 , ... The American College of ... new Lifestyle Medicine Residency Curriculum (LMRC). The curriculum is the first comprehensive, applicable ... Driven by resident involvement, the curriculum has included residents in every aspect ...
(Date:2/19/2020)... ... February 19, 2020 , ... BPM+ Health , ... that it will participate in the HIMSS20 Global Health Conference & ... healthcare professionals and other stakeholders at HIMSS20 – the largest global health information ...
(Date:2/16/2020)... ... February 16, 2020 , ... Accumen Inc., the leader ... AABB and The Joint Commission to provide a complimentary series of Patient Blood ... coordinators and transfusion safety officers) within U.S. hospitals. , “Accumen’s mission ...
(Date:2/15/2020)... ... , ... It all started back in 2010, when Jennifer Martinez (Founder) was ... she was on to something special. The Heartsters have now become a circle ... a health condition or illness, a disability or just having a bad day. ...
(Date:2/14/2020)... ... February 14, 2020 , ... ... by excess weight, skin texture and discoloration, and lines and wrinkles. And the ... MilfordMD is offering some great specials in February specifically to address the areas ...
Breaking Medicine News(10 mins):
... 46 million U.S. adults lacked health insurance, CDC finds , ... care reform may be arriving none too soon: The number ... 2.9 million people from 2008 to 2009. , In ... available -- 46.3 million American adults had no health insurance, ...
... event of the year: the Living Planet Symposium, in ... observation, highlighting the results and ESA,s planned missions, as ... worldwide. In addition to presenting the contributions that ... our understanding of Earth,s environment and climate change over ...
... effects limited to the mouth, smokeless tobacco affects the ... in almost every organ in the body, according to ... journal Chemical Research in Toxicology . The enzymes ... sex hormones estrogen and testosterone; production of cholesterol and ...
... experiences in childhood and adolescence having sparked so many ... simple, safe, and inexpensive way for kids to participate ... heart of lab-on-a chip, inkjet printing, DNA chip, and ... from Jell-O type dessert mixes and Popsicle-type sticks, and ...
... enhance the breakdown of oil from the Gulf of Mexico ... topics in a comprehensive status report that is the cover ... weekly newsmagazine. C&EN Senior Correspondent Jeff Johnson and ... and industry officials continue to struggle with how to handle ...
... ... just a handful of colleges and online universities can be time consuming, confusing, and intimidating ... for you. But College Equalizer, a new revolutionary college search and counseling service is ... ...
Cached Medicine News:
Angled insertion forcep used for the Hydroview lens. Manufactured in titanium....
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
30 degree angled tip with 45 mm tip opening. Made with lock. Manufactured in titanium....
Straight 25 gauge shaft with angled tip and sliding inner shaft. Shaft holds the proximal loop against the angled tip while handle in the normal state. Squeeze type handle with dull finish....
Medicine Products:
(Date:2/19/2020)... , ... February 19, 2020 , ... ... types of platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable ... In 2019, the market for molecular cancer diagnostics, including histology and assays, reached ...
(Date:2/19/2020)... ... February 19, 2020 , ... The Edvocate, an ... and universities for people with disabilities. , The Edvocate highlighted institutions that ... succeed in higher education. AIC placed in the top ten with the following ...
(Date:2/16/2020)... ... February 16, 2020 , ... In Partnership with the Smiles ... at its Kennewick, WA office. , A limited number of appointments are available, but ... For more information or to schedule an appointment, please call (509)-820-4302. , Who: Bright ...
Breaking Medicine Technology:
... DUBLIN, March 16 Shire plc (LSE: ... specialty biopharmaceutical company, announces that it has,decided ... (MAA),for DAYTRANA(TM) (methylphenidate transdermal system) for the ... request from European,regulators to conduct an additional ...
... Professor John F. Thompson Presented Results at The Sixth ... New York City -- Detailed Efficacy Data to be ... KNOXVILLE, Tenn., March 16 Provectus Pharmaceuticals, Inc. (OTC ... company, announced that the interim safety and efficacy results ...
Cached Medicine Technology: